In the Asia Pacific region, countries like China, Japan, and South Korea are experiencing rapid growth in the in vitro diagnostics market. China is the largest market in the region, driven by a large population base and increasing healthcare expenditure. Japan and South Korea are also witnessing growth due to the rising geriatric population and the prevalence of infectious diseases.
In Europe, the United Kingdom, Germany, and France are the key markets for in vitro diagnostics. These countries have a strong healthcare system and are investing in the development of innovative diagnostic technologies. The increasing adoption of point-of-care testing and molecular diagnostics is expected to drive the market growth in Europe.